Repair of Postoperative Cervical Pseudomeningocele with the Use of Bone Morphogenetic Protein

Dejan Slavnic1, Robert Mccabe1, Doris Tong1

  • 1Neurosurgery, Ascension Providence Hospital, Michigan State University, College of Human Medicine, Southfield, USA.

Cureus
|October 1, 2019
PubMed

Insights

This case study highlights the successful treatment of a recurrent cerebrospinal fluid (CSF) leak using recombinant human bone morphogenetic protein-2 (rhBMP-2). The innovative approach led to complete symptom resolution and prevented further CSF leaks after surgery.

Area of Science:

  • Neurosurgery
  • Regenerative Medicine
  • Biomaterials

Background:

  • Recurrent cerebrospinal fluid (CSF) leaks post-surgery present significant clinical challenges.
  • Cervical schwannoma resection can lead to complications like pseudomeningoceles and CSF leaks.
  • Effective management of dural defects is crucial to prevent morbidity and mortality.

Observation:

  • A 25-year-old male developed a symptomatic pseudomeningocele eight days after cervical schwannoma resection.
  • Initial treatment with a lumbar drain was ineffective.
  • A dural sleeve defect at the C3 nerve root was surgically repaired using DuraGen®, muscle/fat graft, and Tisseel®.

Findings:

  • Recombinant human bone morphogenetic protein-2 (rhBMP-2) was applied to the repair site.
  • The patient experienced complete clinical resolution of symptoms at 15 months and radiographic resolution at 16 months.
  • No adverse events such as infection, ectopic bone formation, or recurrent CSF leak were observed.

Implications:

  • This case demonstrates the potential efficacy of rhBMP-2 in treating recurrent symptomatic cervical pseudomoceles.
  • rhBMP-2 may promote dural scarring, aiding in the resolution of CSF leaks.
  • Further research into rhBMP-2's role in managing complex dural defects is warranted.

Related Concept Videos